Oncolytics Biotech Stock Price History
| ONCY Stock | USD 1.27 0.05 3.79% |
Below is the normalized historical share price chart for Oncolytics Biotech extending back to October 05, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oncolytics Biotech stands at 1.27, as last reported on the 20th of July, with the highest price reaching 1.33 and the lowest price hitting 1.24 during the day.
If you're considering investing in Oncolytics Stock, it is important to understand the factors that can impact its price. Oncolytics Biotech is extremely dangerous given 3 months investment horizon. Oncolytics Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.2, which implies the firm had a 0.2 % return per unit of risk over the last 3 months. We were able to break down thirty different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use Oncolytics Biotech Semi Deviation of 4.08, risk adjusted performance of 0.1861, and Coefficient Of Variation of 526.6 to evaluate company specific risk that cannot be diversified away.
At this time, Oncolytics Biotech's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 30.1 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 5.7 M in 2025. . At this time, Oncolytics Biotech's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.87 in 2025, whereas Price To Sales Ratio is likely to drop 66.80 in 2025. Oncolytics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 1999 | 200 Day MA 0.793 | 50 Day MA 0.669 | Beta 1.192 |
Oncolytics | Build AI portfolio with Oncolytics Stock |
Sharpe Ratio = 0.2022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ONCY | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.62 actual daily | 68 68% of assets are less volatile |
Expected Return
| 1.54 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Oncolytics Biotech is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncolytics Biotech by adding it to a well-diversified portfolio.
Oncolytics Biotech Stock Price History Chart
There are several ways to analyze Oncolytics Stock price data. The simplest method is using a basic Oncolytics candlestick price chart, which shows Oncolytics Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 17, 2025 | 1.32 |
| Lowest Price | June 5, 2025 | 0.33 |
Oncolytics Biotech July 20, 2025 Stock Price Synopsis
Various analyses of Oncolytics Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Oncolytics Stock. It can be used to describe the percentage change in the price of Oncolytics Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Oncolytics Stock.| Oncolytics Biotech Price Daily Balance Of Power | (0.56) | |
| Oncolytics Biotech Price Action Indicator | (0.04) | |
| Oncolytics Biotech Price Rate Of Daily Change | 0.96 |
Oncolytics Biotech July 20, 2025 Stock Price Analysis
Oncolytics Stock Price History Data
The price series of Oncolytics Biotech for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 0.99 with a coefficient of variation of 41.19. The daily prices for the period are spread out with arithmetic mean of 0.64. The median price for the last 90 days is 0.57. The company underwent 10:95 stock split on 25th of May 2018. Oncolytics Biotech issued dividends to stockholders on 2018-05-25.| Open | High | Low | Close | Volume | ||
07/20/2025 | 1.30 | 1.33 | 1.24 | 1.27 | ||
07/18/2025 | 1.30 | 1.33 | 1.24 | 1.27 | 1,194,841 | |
07/17/2025 | 1.30 | 1.35 | 1.25 | 1.32 | 1,244,772 | |
| 07/16/2025 | 1.14 | 1.27 | 1.14 | 1.25 | 1,761,419 | |
| 07/15/2025 | 1.20 | 1.20 | 1.11 | 1.13 | 649,683 | |
07/14/2025 | 1.16 | 1.23 | 1.13 | 1.20 | 696,222 | |
07/11/2025 | 1.12 | 1.19 | 1.04 | 1.18 | 1,058,788 | |
| 07/10/2025 | 1.17 | 1.18 | 1.05 | 1.12 | 1,803,533 | |
| 07/09/2025 | 1.31 | 1.31 | 1.10 | 1.20 | 2,491,179 | |
| 07/08/2025 | 1.03 | 1.27 | 1.00 | 1.25 | 3,747,695 | |
07/07/2025 | 0.89 | 1.03 | 0.85 | 1.01 | 2,623,154 | |
07/03/2025 | 0.80 | 0.96 | 0.77 | 0.92 | 1,535,748 | |
07/02/2025 | 0.75 | 0.79 | 0.71 | 0.79 | 3,074,270 | |
07/01/2025 | 0.81 | 0.81 | 0.74 | 0.75 | 1,032,499 | |
| 06/30/2025 | 0.75 | 0.79 | 0.75 | 0.77 | 654,898 | |
06/27/2025 | 0.80 | 0.80 | 0.74 | 0.75 | 1,592,451 | |
06/26/2025 | 0.69 | 0.78 | 0.69 | 0.72 | 1,891,919 | |
06/25/2025 | 0.68 | 0.71 | 0.66 | 0.69 | 567,973 | |
06/24/2025 | 0.62 | 0.67 | 0.62 | 0.67 | 519,634 | |
06/23/2025 | 0.70 | 0.72 | 0.56 | 0.64 | 914,521 | |
06/20/2025 | 0.76 | 0.77 | 0.69 | 0.69 | 999,831 | |
| 06/18/2025 | 0.67 | 0.75 | 0.66 | 0.74 | 1,591,364 | |
06/17/2025 | 0.65 | 0.70 | 0.56 | 0.67 | 925,468 | |
06/16/2025 | 0.61 | 0.65 | 0.58 | 0.64 | 690,284 | |
06/13/2025 | 0.58 | 0.61 | 0.54 | 0.61 | 759,058 | |
06/12/2025 | 0.60 | 0.61 | 0.49 | 0.58 | 3,729,603 | |
| 06/11/2025 | 0.46 | 0.59 | 0.43 | 0.57 | 3,613,223 | |
06/10/2025 | 0.47 | 0.47 | 0.42 | 0.43 | 776,110 | |
06/09/2025 | 0.38 | 0.45 | 0.37 | 0.44 | 1,285,553 | |
06/06/2025 | 0.34 | 0.36 | 0.33 | 0.36 | 684,457 | |
06/05/2025 | 0.35 | 0.35 | 0.33 | 0.33 | 654,043 | |
06/04/2025 | 0.34 | 0.34 | 0.34 | 0.34 | 403,341 | |
06/03/2025 | 0.37 | 0.37 | 0.33 | 0.35 | 753,518 | |
06/02/2025 | 0.35 | 0.36 | 0.33 | 0.34 | 678,664 | |
05/30/2025 | 0.38 | 0.38 | 0.34 | 0.34 | 933,438 | |
05/29/2025 | 0.38 | 0.40 | 0.36 | 0.36 | 1,026,024 | |
05/28/2025 | 0.41 | 0.41 | 0.38 | 0.38 | 756,335 | |
05/27/2025 | 0.42 | 0.42 | 0.39 | 0.40 | 711,499 | |
05/23/2025 | 0.40 | 0.44 | 0.37 | 0.42 | 7,108,686 | |
05/22/2025 | 0.42 | 0.45 | 0.40 | 0.40 | 837,675 | |
05/21/2025 | 0.42 | 0.44 | 0.41 | 0.42 | 730,164 | |
05/20/2025 | 0.44 | 0.45 | 0.41 | 0.43 | 661,154 | |
05/19/2025 | 0.47 | 0.50 | 0.42 | 0.44 | 667,215 | |
| 05/16/2025 | 0.49 | 0.50 | 0.45 | 0.47 | 929,077 | |
05/15/2025 | 0.50 | 0.53 | 0.50 | 0.50 | 438,981 | |
05/14/2025 | 0.52 | 0.54 | 0.51 | 0.52 | 261,784 | |
05/13/2025 | 0.53 | 0.54 | 0.52 | 0.53 | 219,727 | |
05/12/2025 | 0.54 | 0.54 | 0.51 | 0.54 | 246,890 | |
05/09/2025 | 0.52 | 0.53 | 0.51 | 0.52 | 113,337 | |
05/08/2025 | 0.51 | 0.54 | 0.51 | 0.54 | 132,575 | |
05/07/2025 | 0.52 | 0.55 | 0.51 | 0.52 | 177,762 | |
05/06/2025 | 0.55 | 0.55 | 0.51 | 0.51 | 204,635 | |
05/05/2025 | 0.56 | 0.57 | 0.54 | 0.55 | 121,417 | |
05/02/2025 | 0.56 | 0.58 | 0.55 | 0.55 | 133,397 | |
05/01/2025 | 0.58 | 0.58 | 0.55 | 0.55 | 260,295 | |
04/30/2025 | 0.60 | 0.60 | 0.55 | 0.57 | 262,473 | |
04/29/2025 | 0.57 | 0.60 | 0.56 | 0.59 | 298,509 | |
04/28/2025 | 0.58 | 0.59 | 0.56 | 0.57 | 435,573 | |
04/25/2025 | 0.59 | 0.59 | 0.55 | 0.56 | 288,438 | |
04/24/2025 | 0.59 | 0.59 | 0.54 | 0.58 | 362,540 | |
04/23/2025 | 0.61 | 0.61 | 0.56 | 0.57 | 259,973 |
About Oncolytics Biotech Stock history
Oncolytics Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncolytics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncolytics Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncolytics Biotech stock prices may prove useful in developing a viable investing in Oncolytics Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 76.5 M | 80.3 M | |
| Net Loss | -22.4 M | -21.2 M |
Oncolytics Biotech Quarterly Net Working Capital |
|
Oncolytics Biotech Stock Technical Analysis
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Oncolytics Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncolytics Biotech's price direction in advance. Along with the technical and fundamental analysis of Oncolytics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncolytics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1861 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | 0.3627 | |||
| Sortino Ratio | 0.2775 | |||
| Treynor Ratio | 4.81 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.